stent

     

Select
Display
Trial Studied trt Control trt patientstagsNCTROB Result

antithrombotics

not classified
DECLARE-LONG II , 2011 -
EXCELLENT, 20116-month dual antiplatelet therapy12 months dual antiplateletNCT00698607negative
PRODIGY, 201124 months of dual antiplatelet treatment6 months dual antiplateletNCT00611286negative
WOESTtriple therapydual antiplatelet therapyNCT00769938 -
RESETEndeavor stent and three months of DAPTstandard 12-month DAPT and other DESNCT01145079negative
ARTIC (extended dual antiplatelet) ongoing 18 months dual antiplatelet12 months dual antiplateletNCT00827411 ongoing
DES-LATE, 2010prolonged dual antiplatelet therapy12 months dual antiplateletNCT00484926Risk of bias negative
DAPT ongoing prolonged dual antiplatelet therapy12 months dual antiplateletNCT00977938 ongoing
OPTIMIZED ongoing prolonged dual antiplatelet therapy12 months dual antiplatelet ongoing
ISAR-SAFE, 200912 months dual antiplatelet6 months dual antiplateletNCT00661206Low risk of bias -
ARTIC adjusted ongoing Monitoring Adjusted Antiplatelet TreatmentCommon Antiplatelet Treatment ongoing
CILON-T, 2010triple antiplateletdual antiplatelet therapyExploratory negative
cilostazol
Kunishima, 1997cilostazolaspirinnegative
Sekiya, 1998cilostazol + aspirinaspirinnegative
Kozuma, 2001cilostazol + aspirinticlopidine + aspirinnegative
Ochiai, 1999cilostazol + aspirinticlopidine + aspirinnegative
Park, 1999cilostazol + aspirinticlopidine + aspirinnegative
Yoon, 1999cilostazol + aspirinticlopidine + aspirinnegative
Kamishirado, 2002cilostazol + aspirinticlopidine + aspirinnegative
clopidogrel
REAL-LATE, ZEST-LATE, 2010clopidogrel+aspirinaspirinNCT00484926negative
GRAVITAS, 2011high-dose clopidogrelnormal-dose clopidogrelNCT00645918Risk of bias negative
Müller, 2000clopidogrel + aspirinticlopidine + aspirinnegative
CLASSICS, 2000clopidogrel + aspirinticlopidine + aspirinnegative
TOPPS, 2001clopidogrel + aspirinticlopidine + aspirinnegative
Piamsomboon, 2001clopidogrel + aspirinticlopidine + aspirinnegative
ticlopidine
STARS (vs aspirin), 1998ticlopidine + aspirinaspirinsuggesting
Hall, 1996ticlopidine + aspirinaspirinnegative
FANTASTIC, 1998ticlopidine + aspirincoumadin + aspirinnegative
ISAR, 1996ticlopidine + aspirincoumadin + aspirinsuggesting
Foussas, 2000ticlopidine + aspirincoumadin + aspirinsuggesting
MATTIS, 1998ticlopidine + aspirincoumadin + aspirinnegative
STARS (vs coumadin+asp), 1998ticlopidine + aspirincoumadin + aspirinsuggesting

dual antiplatelet therapy

not classified
OPTIMIZE, 20133 months DAPT 12 months DAPTNCT01113372 -
EXCELLENT, 20116-month dual antiplatelet therapy12 months dual antiplateletNCT00698607negative
PRODIGY, 201124 months of dual antiplatelet treatment6 months dual antiplateletNCT00611286negative
RESETEndeavor stent and three months of DAPTstandard 12-month DAPT and other DESNCT01145079negative
ARTIC (extended dual antiplatelet) ongoing 18 months dual antiplatelet12 months dual antiplateletNCT00827411 ongoing
DES-LATE, 2010prolonged dual antiplatelet therapy12 months dual antiplateletNCT00484926Risk of bias negative
DAPT ongoing prolonged dual antiplatelet therapy12 months dual antiplateletNCT00977938 ongoing
OPTIMIZED ongoing prolonged dual antiplatelet therapy12 months dual antiplatelet ongoing
ITALIC ongoing 6 months DAPT24 months DAPTNCT01476020 ongoing
ISAR-SAFE, 200912 months dual antiplatelet6 months dual antiplateletNCT00661206Low risk of bias -
ARTIC adjusted ongoing Monitoring Adjusted Antiplatelet TreatmentCommon Antiplatelet Treatment ongoing
clopidogrel
REAL-LATE, ZEST-LATE, 2010clopidogrel+aspirinaspirinNCT00484926negative
GRAVITAS, 2011high-dose clopidogrelnormal-dose clopidogrelNCT00645918Risk of bias negative